436 related articles for article (PubMed ID: 29554312)
1. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.
Kovesdy CP; Matsushita K; Sang Y; Brunskill NJ; Carrero JJ; Chodick G; Hasegawa T; Heerspink HL; Hirayama A; Landman GWD; Levin A; Nitsch D; Wheeler DC; Coresh J; Hallan SI; Shalev V; Grams ME;
Eur Heart J; 2018 May; 39(17):1535-1542. PubMed ID: 29554312
[TBL] [Abstract][Full Text] [Related]
2. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
[TBL] [Abstract][Full Text] [Related]
3. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
de Rooij ENM; de Fijter JW; Le Cessie S; Hoorn EJ; Jager KJ; Chesnaye NC; Evans M; Windahl K; Caskey FJ; Torino C; Szymczak M; Drechsler C; Wanner C; Dekker FW; Hoogeveen EK;
Am J Kidney Dis; 2023 Sep; 82(3):257-266.e1. PubMed ID: 37182596
[TBL] [Abstract][Full Text] [Related]
4. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
Nakhoul GN; Huang H; Arrigain S; Jolly SE; Schold JD; Nally JV; Navaneethan SD
Am J Nephrol; 2015; 41(6):456-63. PubMed ID: 26228532
[TBL] [Abstract][Full Text] [Related]
5. Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.
Inker LA; Grams ME; Levey AS; Coresh J; Cirillo M; Collins JF; Gansevoort RT; Gutierrez OM; Hamano T; Heine GH; Ishikawa S; Jee SH; Kronenberg F; Landray MJ; Miura K; Nadkarni GN; Peralta CA; Rothenbacher D; Schaeffner E; Sedaghat S; Shlipak MG; Zhang L; van Zuilen AD; Hallan SI; Kovesdy CP; Woodward M; Levin A;
Am J Kidney Dis; 2019 Feb; 73(2):206-217. PubMed ID: 30348535
[TBL] [Abstract][Full Text] [Related]
6. [The prevalence, influencing factors and prognosis of abnormal serum potassium levels in patients with chronic kidney disease].
Wang F; Yang C; Gao BX; Zhang LX; Zhao MH; Wang JW
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(42):3459-3465. PubMed ID: 34775702
[No Abstract] [Full Text] [Related]
7. Association of Albuminuria and Regression of Chronic Kidney Disease in Adults With Newly Diagnosed Moderate to Severe Chronic Kidney Disease.
Pasternak M; Liu P; Quinn R; Elliott M; Harrison TG; Hemmelgarn B; Lam N; Ronksley P; Tonelli M; Ravani P
JAMA Netw Open; 2022 Aug; 5(8):e2225821. PubMed ID: 35943741
[TBL] [Abstract][Full Text] [Related]
8. Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.
Chen Y; Chang AR; McAdams DeMarco MA; Inker LA; Matsushita K; Ballew SH; Coresh J; Grams ME
Mayo Clin Proc; 2016 Oct; 91(10):1403-1412. PubMed ID: 27499535
[TBL] [Abstract][Full Text] [Related]
9. Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project.
Gasparini A; Evans M; Barany P; Xu H; Jernberg T; Ärnlöv J; Lund LH; Carrero JJ
Nephrol Dial Transplant; 2019 Sep; 34(9):1534-1541. PubMed ID: 30085251
[TBL] [Abstract][Full Text] [Related]
10. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
[TBL] [Abstract][Full Text] [Related]
11. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.
Linde C; Qin L; Bakhai A; Furuland H; Evans M; Ayoubkhani D; Palaka E; Bennett H; McEwan P
ESC Heart Fail; 2019 Apr; 6(2):280-290. PubMed ID: 30629342
[TBL] [Abstract][Full Text] [Related]
12. Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.
Luo J; Brunelli SM; Jensen DE; Yang A
Clin J Am Soc Nephrol; 2016 Jan; 11(1):90-100. PubMed ID: 26500246
[TBL] [Abstract][Full Text] [Related]
13. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
14. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials.
Neuen BL; Oshima M; Agarwal R; Arnott C; Cherney DZ; Edwards R; Langkilde AM; Mahaffey KW; McGuire DK; Neal B; Perkovic V; Pong A; Sabatine MS; Raz I; Toyama T; Wanner C; Wheeler DC; Wiviott SD; Zinman B; Heerspink HJL
Circulation; 2022 May; 145(19):1460-1470. PubMed ID: 35394821
[TBL] [Abstract][Full Text] [Related]
15. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.
Coresh J; Heerspink HJL; Sang Y; Matsushita K; Arnlov J; Astor BC; Black C; Brunskill NJ; Carrero JJ; Feldman HI; Fox CS; Inker LA; Ishani A; Ito S; Jassal S; Konta T; Polkinghorne K; Romundstad S; Solbu MD; Stempniewicz N; Stengel B; Tonelli M; Umesawa M; Waikar SS; Wen CP; Wetzels JFM; Woodward M; Grams ME; Kovesdy CP; Levey AS; Gansevoort RT;
Lancet Diabetes Endocrinol; 2019 Feb; 7(2):115-127. PubMed ID: 30635225
[TBL] [Abstract][Full Text] [Related]
16. Reduced Kidney Function, Albuminuria, and Risks for All-cause and Cardiovascular Mortality in China: A Population-based Cohort Study.
Wang J; Wang F; Liu S; Zhou M; Zhang L; Zhao M
BMC Nephrol; 2017 Jun; 18(1):188. PubMed ID: 28592243
[TBL] [Abstract][Full Text] [Related]
17. Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease.
Al-Wahsh H; Tangri N; Quinn R; Liu P; Ferguson Ms T; Fiocco M; Lam Md MSc NN; Tonelli M; Ravani P
JAMA Netw Open; 2021 May; 4(5):e219225. PubMed ID: 33944922
[TBL] [Abstract][Full Text] [Related]
18. Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink.
Furuland H; McEwan P; Evans M; Linde C; Ayoubkhani D; Bakhai A; Palaka E; Bennett H; Qin L
BMC Nephrol; 2018 Aug; 19(1):211. PubMed ID: 30134846
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Savarese G; Xu H; Trevisan M; Dahlström U; Rossignol P; Pitt B; Lund LH; Carrero JJ
JACC Heart Fail; 2019 Jan; 7(1):65-76. PubMed ID: 30553905
[TBL] [Abstract][Full Text] [Related]
20. Age and association of kidney measures with mortality and end-stage renal disease.
Hallan SI; Matsushita K; Sang Y; Mahmoodi BK; Black C; Ishani A; Kleefstra N; Naimark D; Roderick P; Tonelli M; Wetzels JF; Astor BC; Gansevoort RT; Levin A; Wen CP; Coresh J;
JAMA; 2012 Dec; 308(22):2349-60. PubMed ID: 23111824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
